Academic Directorate of Specialised Cancer
The Academic Directorate of Specialised Cancer is comprised of Clinical Oncology and Radiation Services and based at Weston Park Hospital (WPH), a purpose built cancer hospital on the University campus site, which provides non-surgical oncology services to adults with cancer across North Trent.
The catchment population is 1.8 million and the Directorate teams register more than 6000 new cancer patients a year either at WPH or in oncology clinics across North Trent.
If you are interested in getting actively involved,, there is a Consumer Research Panel that aims to engage both cancer patients and carers in the process of research into the causes, treatment and palliation of cancer illnesses. For more information please click here
To view the Research Strategy for the Academic Directorate of Specialised Cancer click here
|Professor Penella Woll||Research Lead & Head of Academic Unit for Oncology|
|Dr Simon Pledge||Clinical Director - Radiation Services|
|Dr Patricia Fisher||Clinical Director - Oncology|
|Ian Scott||General Manager|
|Flora Hawksbee||Deputy General Manager|
|Nigel Leek||Group Finance Manager|
|Yasmin Hussain||Directorate Accountant|
|Clinical Research Office Coordinator (All Studies)|
Clinical Research Office Coordinator
Sheffield Cancer Research Centre
The Directorate is a leading component of the Sheffield Cancer Research Centre jointly funded by Cancer Research UK (CR-UK) and Yorkshire Cancer Research (YCR) and supported by our own local research charity, Weston Park Hospital Cancer Charity (WPHCC). Professor Coleman is the Lead for the Centre. The Centre is one of 18 “Centres of Excellence” across the UK integrating clinical, translational and basic cancer research.
Cancer Clinical Trials Centre
The Cancer Clinical Trials Centre, based within Weston Park Hospital, consists of an experienced and flourishing multi-disciplinary research team that conducts high quality clinical research studies to the exacting standards expected by the scientific community and demanded by the regulatory authorities. Research is conducted into the effects of a wide range of new treatments on the quality of patients' lives.